Press Release August 22, 2006

Boston Millennia Partners Secures $13.1 Million P.E. Financing

BOSTON, August 22, 2006 — Boston Millennia Partners announced the closing of a $13.1 million Series A preferred stock financing of Histogenics Corporation.  Histogenics focuses on the repair of articular cartilage damage utilizing advancements in cell biology, tissue culture, engineering and materials science to affect tissue repair. Millennia Partners led the financing round, with additional participation by Foundation Medical Partners and Stryker Corporation.

Goodwin Procter partner Mitchell Bloom and associate Jaime Genua represented Boston Millennia Partners in this transaction.